Amphiregulin antisense oligonucleotide inhibits the growth of T3M4 human pancreatic cancer cells and sensitizes the cells to EGF receptor-targeted therapy
- 29 July 1997
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 72 (3) , 512-517
- https://doi.org/10.1002/(sici)1097-0215(19970729)72:3<512::aid-ijc21>3.0.co;2-c
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Cytotoxic Effects of TGF-α-Pseudomonas Exotoxin A Fusion Protein in Human Pancreatic Carcinoma CellsPancreas, 1996
- COOH-terminal Extended Recombinant Amphiregulin with Bioactivity Comparable with Naturally Derived Growth FactorPublished by Elsevier ,1996
- Amphiregulin anti‐sense oligodeoxynucleotides inhibit growth and transformation of a human colon carcinoma cell lineInternational Journal of Cancer, 1995
- Induction and Expression of Heparin-Binding EGF-Like Growth Factor in Human Pancreatic CancerBiochemical and Biophysical Research Communications, 1994
- Expression of Amphiregulin, a Novel Gene of the Epidermal Growth Factor Family, in Human Gastric CarcinomasJapanese Journal of Cancer Research, 1993
- Overexpression of the epidermal growth factor receptor in human pancreatic cancer is associated with concomitant increases in the levels of epidermal growth factor and transforming growth factor alpha.Journal of Clinical Investigation, 1992
- Growth factor signaling by receptor tyrosine kinasesNeuron, 1992
- Response to and expression of amphiregulin by ovarian carcinoma and normal ovarian surface epithelial cells: Nuclear localization of endogenous amphiregulinBiochemical and Biophysical Research Communications, 1991
- Structure and Function of Human Amphiregulin: A Member of the Epidermal Growth Factor FamilyScience, 1989
- Journey to the Center of the Cell: Role of the ReceptosomeScience, 1981